Esperion Therapeutics Inc. [NASDAQ: ESPR] loss -2.61% on the last trading session, reaching $2.61 price per share at the time. The company report on February 16, 2024 at 4:30 PM that Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4). The 2017 Inducement Equity Incentive
Esperion Therapeutics Inc. [NASDAQ: ESPR] traded at a high on Thursday, posting a 1.92 gain after which it closed the day’ session at $2.66. The company report on February 13, 2024 at 8:00 AM that Esperion to Report Fourth Quarter and Full Year 2023 Financial
Esperion Therapeutics Inc. [NASDAQ: ESPR] gained 8.68% on the last trading session, reaching $2.38 price per share at the time. The company report on February 1, 2024 at 2:00 PM that RFK, Esperion Therapeutics Announce 2024 Promotional Schedule. NEXLETOL and NEXLIZET to Ride Along RFK
Esperion Therapeutics Inc. [NASDAQ: ESPR] stock went on a downward path that fall over -6.91% on Tuesday, amounting to a one-week price decrease of less than -5.16%. The company report on January 23, 2024 at 4:00 PM that Esperion Announces Closing of Public Offering of
© 2024, Powered by Smart TechOne
